Wave Life Sciences Ltd [WVE] stock is trading at $6.95, down -1.56%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The WVE shares have gain 6.92% over the last week, with a monthly amount glided 2.96%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on April 29, 2025, and set its price target to $10. On April 08, 2025, Wedbush initiated with a Outperform rating and assigned a price target of $18 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $26 on February 25, 2025. Raymond James upgraded its rating to a Strong Buy but $22 remained the price target by the analyst firm on October 16, 2024. In a note dated September 19, 2024, B. Riley Securities initiated an Buy rating and provided a target price of $11 on this stock.
Wave Life Sciences Ltd [WVE] stock has fluctuated between $5.04 and $16.74 over the past year. Currently, Wall Street analysts expect the stock to reach $22.14 within the next 12 months. Wave Life Sciences Ltd [NASDAQ: WVE] shares were valued at $6.95 at the most recent close of the market. An investor can expect a potential return of 218.56% based on the average WVE price forecast.
Analyzing the WVE fundamentals
Wave Life Sciences Ltd [NASDAQ:WVE] reported sales of 104.94M for the trailing twelve months, which represents a drop of -26.82%. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -1.2%, Pretax Profit Margin comes in at -1.07%, and Net Profit Margin reading is -1.07%. To continue investigating profitability, this company’s Return on Assets is posted at -0.39, Equity is -0.86 and Total Capital is -0.63. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.81 points at the first support level, and at 6.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.12, and for the 2nd resistance point, it is at 7.28.
Ratios To Look Out For
For context, Wave Life Sciences Ltd’s Current Ratio is 2.95. As well, the Quick Ratio is 2.95, while the Cash Ratio is 2.78. Considering the valuation of this stock, the price to sales ratio is 10.30, the price to book ratio is 6.23.
Transactions by insiders
Recent insider trading involved Verdine Gregory L., Director, that happened on Jun 13 ’25 when 30000.0 shares were sold. Director, GREGORY VERDINE completed a deal on Jun 13 ’25 to buy 30000.0 shares. Meanwhile, Director HENRY CHRISTIAN O sold 10500.0 shares on Mar 20 ’25.
